32
Participants
Start Date
February 6, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Oral Carbohydrate (CHO) Administration for Hypoglycemia Prevention and Treatment
The intervention in the REMODAL trial involves administering specific amounts of oral carbohydrates (CHO) at different glucose thresholds to evaluate the effectiveness of proactive versus reactive hypoglycemia management strategies in adults with Type 1 diabetes using continuous glucose monitoring (CGM). Participants will undergo three distinct interventions, each designed to test a different amount and timing of CHO intake.
RECRUITING
Institut de recherches cliniques de Montréal, Montreal
RECRUITING
Montreal Clinical Research Institute, Montreal
Institut de Recherches Cliniques de Montreal
OTHER